Targeting the HIV integration process in antiviral therapy.
Melissa
M
McNeely
Frauke
F
Christ
Wannes
W
Thys
Zeger
Z
Debyser
D006678:HIV / Q000201:enzymology / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D019428:HIV Integrase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D011760:Pyrrolidinones / Q000494:pharmacology / Q000627:therapeutic use; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use; D000068898:Raltegravir Potassium; D016662:Virus Integration / Q000187:drug effects*
D019428:HIV Integrase Inhibitors; D011760:Pyrrolidinones; D015363:Quinolones; D000068898:Raltegravir Potassium; C509700:elvitegravir